The CD133+CD44+ precancerous subpopulation of oval cells is a therapeutic target for hepatocellular carcinoma.
Zheng YW, Tsuchida T, Shimao T, Li B, Takebe T, Zhang RR, Sakurai Y, Ueno Y, Sekine K, Ishibashi N, Imajima M, Tanaka T, Taniguchi H.
Zheng YW, et al. Among authors: tsuchida t.
Stem Cells Dev. 2014 Sep 15;23(18):2237-49. doi: 10.1089/scd.2013.0577. Epub 2014 Jun 26.
Stem Cells Dev. 2014.
PMID: 24804872
Free PMC article.